BG IRIS Research Client Login
Transactions
Services
Overview
Solutions
Sector expertise
Research
Insights
Overview
White Papers
Blog
Reports
About us
Overview
Senior Team
News
Events
Careers
Overview
Early careers
Experienced hires
Employee Growth Stories
Media
Press
Videos
Contact
Search
BG IRIS Research Client Login
Healthcare
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Medincell, an innovative pharmaceutical company developing a portfolio of long-acting injectable products, on a EUR 42.9m Follow-on Offering
Bryan, Garnier & Co acts as Joint Bookrunner on Faron Pharmaceuticals' EUR 12 million Follow-On Offering
Bryan, Garnier & Co acts as Sole Financial Advisor on Median Technologies' EUR 10 million Bridge Financing
Bryan, Garnier & Co acts as Sole Financial Advisor, Joint Global Coordinator & Joint Bookrunner on Exact Therapeutics' NOK 145m Follow-On Offering anchored for USD 7m by GE Healthcare
Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on ONWARD Medical's EUR 50m Follow-On Offering, anchored for EUR 22.5m by a Cornerstone Investment from Ottobock
Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics' SEK 300 million Follow-On Offering
Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva's EUR 61.2m Follow-On Offering
Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Nicox's Euronext Paris EUR 3.3m Rights Issue
Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma's SEK 715m Nasdaq Stockholm IPO
Bryan, Garnier & Co acts as Sole Financial Advisor to German medical device CRO/CDMO seleon GmbH
1
2
3
…
18
Privacy Preference Center
Privacy Preferences